# Evaluation of CLP in Heart Failure Patients With Chronic Kidney Disease

Study · id `cardio:ct-nct01265524` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01265524](<https://clinicaltrials.gov/study/NCT01265524>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT01265524

Browse, organ or system: Heart  
Browse, condition area: Heart failure  

## In plain language

A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 113 participants.

## Technical summary

Registry record NCT01265524. Randomized; quadruple masking; primary purpose prevention. Start 2011-04 (registry gives no type); primary completion 2011-11 (actual). Results posted on 2013-03-13.

## Key facts

- Design: Interventional study; randomized; quadruple masking; primary purpose prevention
- Phase: Phase 2
- Enrolled: 113 participants (enrolled count; ClinicalTrials.gov record NCT01265524, source copy `cardio:ctgov-nct01265524-2013-03-13`, retrieved 2026-10-26)
- Start date: 2011-04 (registry gives no type) (ClinicalTrials.gov record NCT01265524, source copy `cardio:ctgov-nct01265524-2013-03-13`, retrieved 2026-10-26)
- Primary completion: 2011-11 (actual) (ClinicalTrials.gov record NCT01265524, source copy `cardio:ctgov-nct01265524-2013-03-13`, retrieved 2026-10-26)
- Completion: Not reported
- Results first posted: 2013-03-13 (ClinicalTrials.gov record NCT01265524, source copy `cardio:ctgov-nct01265524-2013-03-13`, retrieved 2026-10-26)
- Countries: Armenia; Georgia; Moldova (ClinicalTrials.gov record NCT01265524, source copy `cardio:ctgov-nct01265524-2013-03-13`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01265524-2013-03-13`, retrieved 2026-10-26)

## The registry's words

- Brief title: Evaluation of CLP in Heart Failure Patients With Chronic Kidney Disease
- Condition: Heart Failure
- Intervention (Drug): CLP
- Intervention (Drug): Placebo
- Lead sponsor: Sorbent Therapeutics
- Lead sponsor class: INDUSTRY
- Collaborator: Pharmaterra
- Collaborator class: UNKNOWN

## Connected pages

- Registry condition terms include this condition: Heart failure (`cardio:heart-failure`)

### Main results

- Registry lists this paper as a reference of type result; PubMed types it as a trial report that names this trial and no other, dated on or after the trial start, and its title marks no secondary, follow-up or other further analysis: A double-blind, randomized, parallel, placebo-controlled study examining the effect of cross-linked polyelectrolyte in heart failure patients with chronic kidney disease (`cardio:pubmed-22613585`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: c8a8bd16b3b7a2bb9247423b13478c716aef336ab41097ea03ba981a43d8563b
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
